萬盛股份(603010.SH):季銨鹽為公司現有叔胺產能的基礎上往下游衍生的新產品,目前已取得一些訂單
格隆匯2月28日丨萬盛股份(603010.SH)於2023年2月接受機構調研時表示,季銨鹽為公司現有叔胺產能的基礎上往下游衍生的新產品,此次季銨鹽的佈局進一步延伸了公司日化原材料領域產業鏈。公司正在積極開拓市場,目前已取得一些訂單。由於季銨鹽是公司新佈局的產品,且季銨鹽系列產品較多,部分產品尚在客户認證中,待認證通過,季銨鹽的銷量將會逐步提高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.